VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

10061	Companies
205647	Keywords
135890	Articles
109032	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 06/04/2025 at 07:00, 9 months 19 days ago

Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction. Assemblée le 25 juin 2025 à Lyon. Consultez le site pour plus d'informations

Annonce Valneva Assemblée Générale Mixte Équipe De Direction Vaccins
BRIEF

published on 05/21/2025 at 13:36, 10 months 1 day ago

Valneva SE: Research Update Reaffirms Buy Rating, Raises Target Price

Target Price Financial Growth Valneva Market Forecast Lyme Vaccine
BRIEF

published on 05/21/2025 at 13:36, 10 months 1 day ago

Valneva SE : une mise à jour de recherche confirme la recommandation d'achat et relève l'objectif de cours

Croissance Financière Valneva Vaccin Contre La Maladie De Lyme Prévisions Du Marché Prix Cible
PRESS RELEASE

published on 05/21/2025 at 13:31, 10 months 1 day ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases price target for Valneva SE to €8.10 following strong Q1/25 results and positive outlook on Lyme disease vaccine candidate, VLA15

First Berlin Equity Research Price Target Valneva SE Lyme Disease Vaccine Q1/25 Results
BRIEF

published on 04/26/2025 at 19:15, 10 months 26 days ago

Suspension partielle de l'utilisation du vaccin IXCHIQ® de Valneva

Sécurité Valneva France Vaccin Chikungunya
BRIEF

published on 04/26/2025 at 19:15, 10 months 26 days ago

Partial suspension of the use of Valneva's IXCHIQ® vaccine

Security Valneva France Vaccine Chikungunya
PRESS RELEASE

published on 04/26/2025 at 19:10, 10 months 26 days ago

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Valneva SE provides an update on the recommendation for the use of its Chikungunya vaccine by French authorities, focusing on adverse events in elderly people. The company is collaborating with regulators on next steps

Valneva SE Chikungunya Vaccine French Authorities Adverse Events Elderly
PRESS RELEASE

published on 04/26/2025 at 19:10, 10 months 26 days ago

Valneva fait un point sur la recommandation d’utilisation de son vaccin contre le chikungunya par les autorités françaises
Valneva met à jour la recommandation d'utilisation de son vaccin IXCHIQ® contre le chikungunya en France suite à des effets indésirables chez les personnes âgées avec comorbidités. Valneva collabore avec les autorités pour assurer la sécurité

Valneva Vaccin Chikungunya Autorités Sanitaires Effets Indésirables
BRIEF

published on 04/18/2025 at 10:05, 11 months 4 days ago

Valneva Updates on Chikungunya Vaccine Recommendation in the U.S.

Valneva Chikungunya Vaccine IXCHIQ® ACIP Recommendation U.S. Travelers
BRIEF

published on 04/18/2025 at 10:05, 11 months 4 days ago

Valneva met à jour sa recommandation concernant le vaccin contre le chikungunya aux États-Unis

Valneva Voyageurs Américains Vaccin Contre Le Chikungunya IXCHIQ® Recommandation De L'ACIP

Accesswire

Published on 03/23/2026 at 08:00, 33 minutes ago

ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 6 hours 33 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 9 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 11 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 11 hours ago

Earthwise Minerals Announces Private Placement

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 08:26, 6 minutes ago

Staking Rush in Ontario: Storm Exploration Secures the Prime Plots in the New Gold Belt
Published on 03/23/2026 at 08:20, 13 minutes ago

Eurobattery Minerals becomes debt-free as the final convertible bonds are fully converted into shares
Published on 03/23/2026 at 08:00, 32 minutes ago

Zentra Group plc: Unaudited interim report for the six months ended 31 December 2025
Published on 03/23/2026 at 08:00, 33 minutes ago

Transaction in Own Shares
Published on 03/23/2026 at 08:00, 33 minutes ago

Notification of the Greenshoe-Option and Stabilization Measures in accordance with Art. 5 (4)(b), (5) and (6) of Reg. (EU) 596/2014 and Art. 8 (f) and Art. 6 (3) Comm. Delegated Reg. (EU) 2016/1052

Les Echos

Published on 03/23/2026 at 08:10, 23 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 13 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 13 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 14 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 14 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE